Kering SA (EPA:PRTP), the luxury group behind Gucci, has agreed to sell its beauty business to L’Oréal SA (EPA:OREP) for €4 billion ($4.66 billion) as part of its strategic shift to strengthen its core fashion operations. The deal, announced on Sunday, marks a major step in Kering’s ongoing efforts to reduce debt and regain financial stability under the leadership of new CEO Luca de Meo.
As part of the agreement, Kering will divest its House of Creed unit to L’Oréal, transferring ownership of the high-end fragrance brand. In addition, L’Oréal will secure 50-year exclusive licenses to develop and distribute fragrances and beauty products for Kering’s prestigious fashion houses—Gucci, Bottega Veneta, and Balenciaga. Both companies have also expressed interest in pursuing future collaborative opportunities to expand their partnership in the global luxury beauty sector.
The sale is seen as a decisive move by Kering to streamline its portfolio and focus on revitalizing its flagship fashion labels, particularly Gucci, which has struggled amid slowing luxury demand in major markets like China. Analysts note that the divestment could help the company significantly reduce its net debt, which has been a growing concern among investors in recent months.
For L’Oréal, the acquisition strengthens its dominance in the luxury fragrance market, adding Kering’s coveted brands to its extensive beauty portfolio. The deal highlights the growing trend of consolidation within the luxury sector as major players aim to adapt to shifting consumer behavior and global economic pressures.
With this transaction, Kering positions itself to rebuild profitability and brand strength, while L’Oréal continues to expand its leadership in premium beauty—a win-win for both French powerhouses.


Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 



